Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

DEPRESSIVE DISORDER Clinical Trial

Official title:

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic. A Neglected Area

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01081197
• Other study ID #: LE_ARP_Somatic_AlcoholAddicts
• Status: Completed
• Start date: March 2010
• Est. completion date: May 2013

Study information

• Verified date: November 2021
• Source: Helse Nord-Trøndelag HF
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.

The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).

Description:

Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: May 2013
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway

Exclusion Criteria:

• Not consenting to participate

• Not able to consent

Related Conditions & MeSH terms

• Alcoholic Neuropathy
• Depressive Disorder
• HEART DISEASE
• Heart Diseases
• Liver Failure

Intervention

Other:
• Psychiatric and somatic examinations and ,if clinical indicated, treatment
Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.

Locations

Country	Name	City	State
Norway	Levanger Hospital, Dep. of Psychiatry	Levanger

Sponsors (1)

Lead Sponsor	Collaborator
Helse Nord-Trøndelag HF

Country where clinical trial is conducted

Norway, 

References & Publications (3)

Awtry EH, Philippides GJ. Alcoholic and cocaine-associated cardiomyopathies. Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):289-99. doi: 10.1016/j.pcad.2009.11.004. Review. — View Citation

Moss M, Burnham EL. Alcohol abuse in the critically ill patient. Lancet. 2006 Dec 23;368(9554):2231-42. Review. — View Citation

Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, Eaton S, Cotsonis GA. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003 Mar;31(3):869-77. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of different kinds of somatic disease	Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.	3 months after inclusion
Secondary	Prevalence of former somatic disease	Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.	3 months after inclusion
Secondary	Outcome of psychiatric and somatic treatment of alcohol abusers	Quality of life and score of somatic and psychiatric health 1 year after inclusion	1 year after stopped inclusion